GlassScriptPhysician profile
Mark J Seifert
NPI 1942201694
$34,516.05
in general payments reported to CMS, 2019-2025
32 companies · $3,808 in 2025
The $3,808 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,610 · 2021: $6,104 · 2022: $2,963 · 2023: $3,930 · 2024: $5,345 · 2025: $3,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,969 · Travel and Lodging: $2,325 · Consulting Fee: $1,450 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,968.94 |
| Travel and Lodging | $2,325.39 |
| Consulting Fee | $1,450.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $338.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,046.82 | 2019-2025 | Aveir, Gallant, Assurity |
| Boston Scientific Corporation | $3,073.00 | 2019-2025 | General - Therapies, Watchman Flx, Farapulse |
| Impulse Dynamics (USA) INC. | $2,236.48 | 2021-2024 | Optimizer, Optimizer |
| Medtronic, INC. | $1,789.09 | 2021-2025 | Na, Pulseselect, Affera Mapping System |
| Cardiofocus, INC. | $1,441.52 | 2019-2023 | Heartlight System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,396.82 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $1,308.37 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Optowire |
| Medical Device Business Services, INC. | $1,263.30 | 2019 | |
| W. L. Gore & Associates, INC. | $1,148.00 | 2021-2025 | Product In Development |
| Biosense Webster, INC. | $752.93 | 2019-2025 | Carto 3, Na, Nuvision Ice Catheter |
| Sanofi-Aventis U.S. LLC | $732.50 | 2019-2024 | |
| Melinta Therapeutics, LLC | $309.00 | 2021 | |
| Angiodynamics, INC. | $227.71 | 2020 | |
| Atricure, INC. | $220.16 | 2022-2024 | |
| Cvrx, INC. | $175.14 | 2021-2024 | Barostim Neo System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $165.72 | 2019-2025 | Kengreal, Cleviprex |
| Medtronic Vascular, INC. | $146.77 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $132.00 | 2019-2021 | |
| Cook Medical LLC | $120.50 | 2021 | |
| Altathera Pharmaceuticals LLC | $116.52 | 2022 | |
| Philips North America LLC | $113.22 | 2023-2025 | Lm Undivided |
| Abiomed | $107.69 | 2021-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $100.97 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $86.18 | 2019-2021 | |
| Bardy Diagnostics, INC. | $85.00 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $65.13 | 2023-2025 | Assure Wcd |
| Akcea Therapeutics, INC. | $50.70 | 2019 | |
| Amgen INC. | $34.47 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.39 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.76 | 2019 | |
| Cardinal Health 200 LLC | $12.97 | 2020 | |
| Amarin Pharma, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Seifert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.